lansoprazole has been researched along with Adamantiades-Behcet Disease in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole (30 mg) was given as a probe drug to evaluate CYP2C19 activity in 59 patients with BD and 27 healthy control volunteers." | 1.46 | Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease. ( Akdogan, A; Babaoglu, MO; Bertilsson, L; Bozkurt, A; Cevik, L; Goktas, MT; Kalkisim, S; Karaca, RO; Kilic, L; Yasar, U, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goktas, MT | 1 |
| Karaca, RO | 1 |
| Kalkisim, S | 1 |
| Cevik, L | 1 |
| Kilic, L | 1 |
| Akdogan, A | 1 |
| Babaoglu, MO | 1 |
| Bozkurt, A | 1 |
| Bertilsson, L | 1 |
| Yasar, U | 1 |
| Kobayashi, S | 1 |
| Kawabe, N | 1 |
| Miyata, F | 1 |
| Ito, H | 1 |
| Kazumiya, H | 1 |
| Murase, K | 1 |
| Kurokawa, S | 1 |
| Fujishima, K | 1 |
2 other studies available for lansoprazole and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Behcet Syndrome; Biotransformatio | 2017 |
[A case of Behcet's syndrome associated with esophageal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Behcet | 1998 |